CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In comparison with normal CD34 + cells, no changes in ETC protein expression was found in CML leukocytes isolated from patient with primary resistance to imatinib (patient 1) or from patient with partial response (patient 2) (Fig. 3F and Table S1).